We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TTNP Titan Pharmaceuticals Inc

0.0022 (0.65%)
Last Updated: 11:55:29
Delayed by 15 minutes


Draw Mode:

Volume 11,757
Bid Price 0.3424
Ask Price 0.35
News -
Day High 0.3675


52 Week Range


Day Low 0.325
Company Name Stock Ticker Symbol Market Type
Titan Pharmaceuticals Inc TTNP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0022 0.65% 0.3424 11:55:29
Open Price Low Price High Price Close Price Prev Close
0.35 0.325 0.3675 0.340201
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
60 11,757 $ 0.33818 $ 3,976 - 0.31 - 1.094
Last Trade Time Type Quantity Stock Price Currency
11:59:48 1 $ 0.3462 USD

Titan Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.96M 15.02M - 557k -10.21M -0.68 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Titan Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No TTNP Message Board. Create One! See More Posts on TTNP Message Board See More Message Board Posts

Historical TTNP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.350.3810.3250.341276915,322-0.0076-2.17%
1 Month0.44410.49490.310.370981221,835-0.1017-22.9%
3 Months0.48790.570.310.402574838,283-0.1455-29.82%
6 Months0.7760.82950.310.537500662,905-0.4336-55.88%
1 Year0.87781.0940.310.645954745,832-0.5354-60.99%
3 Years4.294.610.312.37323,851-3.95-92.02%
5 Years59.9477.400.317.974,268,754-59.60-99.43%

Titan Pharmaceuticals Description

Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides efficacy and/or safety benefit. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate, or EVA, and a drug substance. Its first product based on ProNeura technology was the Probuphine (buprenorphine) implant, which was approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less a day of oral buprenorphine.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |